Glibenclamide is used in the treatment of type 2 diabetes. It is available as a generic medication. It may be used with other antidiabetic medication. Reference standards of Glibenclamide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Glibenclamide (IPRS/12/12)-from IPC [catalogue_number] => PA IPIPRS 12 12 [category_ids] => ,151, [chemical_name] => [weight] => NA [form] => [cas] => NA [pslug] => glibenclamide-iprs-12-12-paipiprs1212 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA IPIPRS 12 12
CAS :
Molecular Formula :
Molecular Weight : NA
stdClass Object ( [pname] => Glibenclamide(IPRS/41/15) [catalogue_number] => PA IPRS 41 15 [category_ids] => ,75,76,70,78,82,151, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => glibenclamide-iprs-41-15-paiprs4115 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA IPRS 41 15
Molecular Formula : NA
stdClass Object ( [pname] => Glibenclamide (IPRSG008) [catalogue_number] => PA IPRSG008 [category_ids] => ,151, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => glibenclamide-iprsg008-paiprsg008 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA IPRSG008
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
